Sept. 28, 2018 — The Drug Enforcement Administration (DEA) has reclassified the epilepsy cannabidiol drug Epidiolex from Schedule I to Schedule V,…
-
-
HealthDay Reporter TUESDAY, Dec. 6, 2016 (HealthDay News) — A purified oral version of a marijuana compound may help with treatment-resistant forms…
